Business● LowOct 19 · Oct 19, 2026, 5:25 PM
AnaptysBio gains as GSK granted FDA label expansion for Jemperli
GlobeAlert Desk · curated from Seeking Alpha Tech · North America
AnaptysBio has seen gains following GSK receiving an FDA label expansion for its drug Jemperli. This indicates a positive development for GSK and a correlated market reaction for AnaptysBio, likely due to partnerships or shared interests.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
North America theater · last 7 days
rising · 27 in the last 24h1,288
events logged
97
risk index / 100
Attacks & Assaults 523Robberies & Theft 406Shootings 226Kidnappings 50Rocket Launches 36
- Houston police searching for man accused of shooting girlfriend at apartment complexShootings · United States · 30m ago
- Cyber activity (108 reports)Cyber Threats · · 43m ago
- Protest activity (87 reports)Protests · · 43m ago
More in Business
Business32m agoBengaluru Metro conducts trial run of Blue Line train at Byappanahalli depotThe HinduBusiness54m agoMeta chief strategy officer Dave Wehner leaves to join AI infrastructure startup Fireworks as CFOCNBCBusiness1h agoBulls vs. Bears: NVIDIA sparks valuation debate as stock nears six-month lowSeeking Alpha TechBusiness1h agoNo complete closure of Ballari Road for 18 months for elevated corridor work: BDAThe Hindu